Novartis to appeal latest setback to stopping Entresto generics

Veronique D/iStock Editorial via Getty Images A federal judge has denied a bid from Novartis to declare that the U.S. FDA's approval of a generic of its heart failure drug Entresto (sacubitril/valsartan) was unlawful.

Judge Dabney L. Friedrich of the U.S.

District Court for the District of Columbia.